News & Updates

Apalutamide for castration-resistant prostate cancer yields real-world results
Apalutamide for castration-resistant prostate cancer yields real-world results
25 Mar 2022

Patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) who have been initiated on apalutamide in a real-world setting appear to show prostate-specific antigen (PSA) response that is strong and consistent with that reported in clinical trials, as reported in a study.

Apalutamide for castration-resistant prostate cancer yields real-world results
25 Mar 2022
Light drinking may protect against death after myocardial infarction
Light drinking may protect against death after myocardial infarction
24 Mar 2022 byStephen Padilla

Following an episode of myocardial infarction (MI), patients with light or moderate alcohol consumption appear to have a lower risk of mortality than nondrinkers, according to a study.

Light drinking may protect against death after myocardial infarction
24 Mar 2022